Related Experiment Videos
Monoclonal antibodies specific for interleukin 3-sensitive murine cells
The Journal of Experimental Medicine
|February 1, 1986
Summary
Monoclonal antibodies CC11 and CB5 target the interleukin-3 (IL-3) receptor on hematopoietic stem cells. These antibodies block IL-3-dependent cell growth, identifying a key molecule for IL-3 signaling.
Area of Science:
- Immunology
- Hematology
- Molecular Biology
Background:
- Interleukin-3 (IL-3) is a critical cytokine for hematopoietic stem cell proliferation and differentiation.
- Identifying the IL-3 receptor is essential for understanding hematopoietic regulation and developing targeted therapies.
Purpose of the Study:
- To characterize the molecule recognized by monoclonal antibodies CC11 and CB5.
- To investigate the role of this molecule in IL-3-dependent cellular processes.
Main Methods:
- Utilized 18 IL-3-dependent cell lines and primary cells from fetal liver and bone marrow.
- Performed immunoprecipitation and Western blotting to determine molecular weight and isoelectric point.
- Assessed antibody effects on cell proliferation and cytokine-mediated responses.
- Investigated IL-3 modulation of cell surface glycoprotein expression.
Main Results:
- Monoclonal antibodies CC11 and CB5 bind to a 50,000-70,000 Mr glycoprotein present on IL-3-dependent cells, including hematopoietic stem and progenitor cells.
- This glycoprotein is absent on cells insensitive to IL-3 and non-hematopoietic tissues.
- CC11 and CB5 specifically inhibit IL-3-driven cell proliferation without affecting responses to other cytokines or mitogens.
- Recombinant IL-3 modulates the expression of this glycoprotein on IL-3-dependent cells.
- Cells expressing the CC11/CB5 glycoprotein proliferate in response to IL-3, while those lacking it do not.
Conclusions:
- The CC11/CB5 reactive molecule is a functional receptor for mouse IL-3.
- This finding provides a novel target for studying and potentially manipulating IL-3 signaling in hematopoiesis.